GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. GOVX, a biotechnology company developing immunotherapies and vaccines against cancers and infectious…#vaccines #atlanta #geovaxlabs #govx #cef #mva #geocm04s1 #cdmoableurope #oxfordbiomedica #daviddodd
Source: Reuters: Health - Category: Consumer Health News Source Type: news